These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure]. Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600 [TBL] [Abstract][Full Text] [Related]
24. Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers. Tedeschi S; Pilotti E; Parenti E; Vicini V; Coghi P; Montanari A; Regolisti G; Fiaccadori E; Cabassi A Metabolism; 2012 Jan; 61(1):37-42. PubMed ID: 21696792 [TBL] [Abstract][Full Text] [Related]
26. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure. Potocki M; Breidthardt T; Reichlin T; Hartwiger S; Morgenthaler NG; Bergmann A; Noveanu M; Freidank H; Taegtmeyer AB; Wetzel K; Boldanova T; Stelzig C; Bingisser R; Christ M; Mueller C J Intern Med; 2010 Jan; 267(1):119-29. PubMed ID: 19570053 [TBL] [Abstract][Full Text] [Related]
27. Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure. Voors AA; Petrie CJ; Petrie MC; Charlesworth A; Hillege HL; Zijlstra F; McMurray JJ; van Veldhuisen DJ Eur Heart J; 2005 Sep; 26(17):1759-64. PubMed ID: 15833758 [TBL] [Abstract][Full Text] [Related]
28. [Better treatment of heart failure by measurements of natriuretic peptides. There are still remaining problems when it comes to the interpretation of measurement levels]. Lindstedt G; Dahlström U; Fernlund P; Schaufelberger M; Stridsberg M Lakartidningen; 2001 Oct; 98(41):4444-8, 4450-2. PubMed ID: 11699251 [TBL] [Abstract][Full Text] [Related]
29. Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide. Hülsmann M; Berger R; Mörtl D; Gore O; Meyer B; Pacher R Eur J Heart Fail; 2005 Jun; 7(4):552-6. PubMed ID: 15921794 [TBL] [Abstract][Full Text] [Related]
30. Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice. Buckley MG; Marcus NJ; Yacoub MH Clin Sci (Lond); 1999 Dec; 97(6):689-95. PubMed ID: 10585896 [TBL] [Abstract][Full Text] [Related]
31. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes. Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435 [TBL] [Abstract][Full Text] [Related]
32. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels. Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065 [TBL] [Abstract][Full Text] [Related]
33. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure. Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330 [TBL] [Abstract][Full Text] [Related]
34. Decreased plasma brain natriuretic peptide levels after a successful maze procedure. Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326 [TBL] [Abstract][Full Text] [Related]